Anthera Pharmaceuticals 

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

Find out more about what we are doing for patients with Cystic Fibrosis, Systemic Lupus Erythematosus, and IgA Nephropathy:

Cystic Fibrosis
Systemic Lupus Erythematosus
IgAN

ANTH on NASDAQ

LATEST NEWS

Anthera Pharmaceuticals Announces Direct Registered Offering. Read more

Anthera Pharmaceuticals Announces Appointment of Dr. William Shanahan Jr. as Chief Medical Officer. Read more

UPCOMING EVENTS

Citi 11th Annual Biotech Conference
September 7, 2016

Print Friendly